Equities

Outset Medical Inc

OM:NSQ

Outset Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.73
  • Today's Change0.19 / 5.37%
  • Shares traded526.74k
  • 1 Year change-82.09%
  • Beta1.9911
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

  • Revenue in USD (TTM)125.08m
  • Net income in USD-168.77m
  • Incorporated2003
  • Employees480.00
  • Location
    Outset Medical Inc3052 Orchard DriveSAN JOSE 95134United StatesUSA
  • Phone+1 (971) 563-3083
  • Fax+1 (302) 655-5049
  • Websitehttps://outsetmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Clearpoint Neuro Inc26.16m-20.63m148.89m107.00--4.30--5.69-0.8326-0.83261.051.260.50371.2610.08244,495.30-39.71-34.75-49.90-39.6757.1064.75-78.84-76.912.61--0.2237--16.5626.64-34.40--75.30--
CVRx Inc42.09m-52.01m150.09m200.00--2.26--3.57-2.48-2.482.013.070.36780.67815.64210,430.00-45.45---48.95--84.45---123.58--10.87-21.110.3064--74.89--0.5528------
InfuSystem Holdings Inc127.41m84.00k152.05m499.002,568.352.9112.371.190.00280.00285.912.461.2310.666.57255,330.700.08114.600.09555.6950.2756.430.06594.071.511.560.36410.0014.4413.384,744.44--6.01--
Stereotaxis Inc27.10m-21.22m159.50m122.00--10.88--5.89-0.2575-0.25750.32880.24390.60121.456.14222,155.70-44.08-25.02-63.05-34.1255.1667.57-73.32-41.901.79--0.00---4.89-1.82-12.33--6.63--
Akso Health Group - ADR2.20m-17.07m161.35m12.00------73.25-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
Accuray Inc430.55m-21.49m175.66m1.02k--4.28--0.408-0.2197-0.21974.420.41390.91781.865.72420,462.90-4.58-1.45-7.84-2.4833.0637.86-4.99-1.620.778-0.38570.8086--4.122.03-73.56--13.92--
Outset Medical Inc125.08m-168.77m192.92m480.00--2.07--1.54-3.38-3.382.501.800.35291.823.53260,577.10-47.61-41.40-54.98-47.2924.615.71-134.93-159.055.32-32.130.6786--13.00130.43-6.04--14.27--
Inogen Inc321.52m-96.68m195.69m834.00--1.02--0.6086-4.15-4.1513.818.150.9176.036.83385,519.20-27.57-8.23-34.28-9.5340.5444.54-30.07-10.312.36--0.00---16.32-2.49-22.30--26.34--
Delcath Systems Inc4.61m-49.79m195.89m76.00--12.27--42.52-2.65-2.650.23570.57470.13820.45454.5660,618.42-149.30-116.57-249.28-243.2170.5471.02-1,080.73-1,235.372.25-42.250.3348---24.05-9.53-30.60---5.26--
Neuropace Inc69.07m-31.51m198.79m171.00--13.84--2.88-1.18-1.182.590.49940.67351.626.63403,935.70-30.72---34.60--73.97---45.61--5.56-4.670.8019--43.72--30.00------
Semler Scientific Inc65.88m21.69m207.24m92.0010.562.619.283.152.782.788.4511.260.85515.138.51716,097.8028.1438.8331.1444.4189.4390.2232.9232.5812.11--0.00--20.2825.9843.6932.64-0.3821--
Butterfly Network Inc68.08m-121.92m209.63m225.00--1.03--3.08-0.5893-0.58930.3290.96850.20450.69544.97302,577.80-36.61---42.07--26.50---179.08--3.34--0.00---10.21--20.76------
Edap Tms SA (ADR)65.63m-19.77m220.95m307.00--3.85--3.37-0.534-0.5341.771.550.63772.393.53213,769.90-19.21-6.62-26.95-9.2240.9143.23-30.12-9.592.00--0.0757--9.649.05-622.06--32.75--
Senseonics Holdings Inc23.30m-80.59m228.28m132.00--12.04--9.80-0.1354-0.13540.0390.10670.16352.516.51176,515.20-56.55-73.65-66.90-106.9712.93-40.41-345.89-649.863.70-11.130.4783--36.623.43-142.49---18.76--
Utah Medical Products, Inc.49.04m16.38m240.96m169.0015.151.9211.154.914.514.5113.5035.600.37272.0913.24290,201.2012.4412.6913.0213.1959.0561.5733.3930.5117.89--0.0037.05-3.933.640.98341.659.711.86
Data as of May 31 2024. Currency figures normalised to Outset Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

57.74%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Mar 20246.75m13.36%
Columbia Wanger Asset Management LLCas of 31 Mar 20243.60m7.13%
Morgan Stanley & Co. LLCas of 31 Mar 20243.55m7.02%
BlackRock Fund Advisorsas of 31 Mar 20243.03m6.01%
The Vanguard Group, Inc.as of 31 Mar 20242.80m5.53%
JPMorgan Investment Management, Inc.as of 31 Mar 20242.44m4.83%
Braidwell LPas of 31 Mar 20242.40m4.75%
D. E. Shaw & Co. LPas of 31 Mar 20241.69m3.34%
Ensign Peak Advisors, Inc.as of 31 Mar 20241.60m3.18%
Threadneedle Asset Management Ltd.as of 31 Mar 20241.31m2.60%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.